According to current guidelines, the surgical treatment of benign prostatic hyperplasia is main therapeutic option, being refractory conservative approach. Transurethral resection prostate and open transvesical adenomectomy have been considered a reference standard in medium (<80ml) large (> 80ml) hyperplasia. To reduce postoperative complications promote faster recovery, there proposed s...

Benign prostatic hyperplasia refers to the non-malignant growth or enlargement of prostate gland and is a general cause lower urinary tract symptoms in men which rises with growing age. There wide range management options available from watchful waiting, medicinal therapy various surgical intervention methods. Though preliminary treatment for benign hyperplasia, some patients lack desire keep o...

Benign prostatic hyperplasia (BPH) is a benign hyperplasia of prostate gland cells of the urethra affecting increasing population. The most common method of treatment is transurethral resection of the prostate (TURP). But many complications may occur including intraoperative or postoperative hemorrhage, prostate perforation, urinary incontinence and bladder neck contracture. Transurethral ballo...

Benign prostatic hyperplasia is a nonmalignant adenomatous enlargement of the periurethral prostate gland. It is a common disease in older men. In addition to man, spontaneous benign prostatic hyperplasia occurs in chimpanzee and the dog. Alternatives to these spontaneous models are induced benign prostatic hyperplasia, xenografts and in vitro models. Xenografts may be induced by cells cultured...

Benign prostatic hyperplasia (BPH) is a benign hyperplasia of prostate gland cells of the urethra affecting increasing population. The most common method of treatment is transurethral resection of the prostate (TURP). But many complications may occur including intraoperative or postoperative hemorrhage, prostate perforation, urinary incontinence and bladder neck contracture. Transurethral ballo...

PURPOSE We describe the trends in transurethral prostatectomy and minimally invasive surgical treatments for benign prostate hyperplasia from 1999 through 2005 among elderly male Medicare beneficiaries. MATERIALS AND METHODS Benign prostatic hyperplasia surgeries were identified using the annual 100% Medicare carrier files which contain physician claims for services reimbursed under Medicare ...

background transurethral resection of the prostate (turp) is the most common surgical treatment for benign prostatic hyperplasia. objectives the aim of the present study was to compare the conventional bipolar transurethral resection of prostate (turp) with a modified transurethral resection of the prostate (m-turp) in men with mild to moderate symptoms of benign prostatic hyperplasia. patients...

The aim of this study was to detect the differences in 90K/Mac-2BP expression in prostate cancer, benign prostatic hyperplasia and normal prostate tissues, as well as to study the significance of 90K/Mac-2BP in the early diagnosis and prognosis of prostate cancer. Comparative proteomic technologies were used in the present study. Total protein from 10 cases of prostate cancer, benign prostatic ...

Prostate gland can be structurally evaluated by computed tomography (CT) with taking advantages of tomographic feature and post-contrast parenchymal changes. The current examination initiated to determine association between computed tomographic and cytological results in evaluation of canine prostate. Thirty mature male dogs were included and under gone by both CT and fine needle sampling of p...

Solitary fibrous tumor (SFT) of prostate is an unusual type of mesenchymal neoplasm that can elicit a benign or malignant phenotype. It represents a diagnostic challenge as it can simulate poorly differentiated adenocarcinoma and various mesenchymal neoplasms of prostate. We report a case of prostate SFT in a 54-year-old patient, which was clinically misdiagnosed as nodular hyperplasia of prost...